CAMP FY 2019 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$125M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$366M+0.6% YoY

Gross Profit

$143M39.1% margin

Operating Income

-$17M-4.6% margin

Net Income

-$79M-21.5% margin

EPS (Diluted)

$-2.34

Cash Flow

Operating Cash Flow

$12M

Free Cash Flow

-$10M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$496M

Total Liabilities

$358M

Stockholders' Equity

$138M

Cash & Equivalents

$107M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$366M	$364M	+0.6%
Gross Profit	$143M	$148M	-3.0%
Operating Income	-$17M	$20M	-185.1%
Net Income	-$79M	$18M	-528.2%